Infection and increased systemic inflammation cause organ dysfunction and death in patients with decompensated cirrhosis. Preclinical studies provide support for an antiinflammatory role of albumin, ...
Please provide your email address to receive an email when new articles are posted on . Targeted human albumin solution increased serum sodium in hospitalized patients with cirrhosis and hyponatremia, ...
Daily infusions of albumin provide no significant health benefit to patients hospitalised with advanced liver disease, over and above 'standard care', finds a large-scale multicentre trial led by UCL ...
Researchers also found an improvement in specialized blood markers focusing on inflammation, endothelial dysfunction, and albumin function in patients receiving weekly albumin injection. Among ...
In the ETERLI study, AKI reversals at 7 days were twice as frequent when patients started terlipressin after 12 hours of albumin infusion compared to the standard initiation at 48 hours (68.6% vs 31.4 ...
BARCELONA, Spain, Nov. 4, 2021 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a leading global producer of plasma-derived medicines, today announced the launch of its latest albumin ...
German scientists have identified a serious and previously misunderstood contaminant that brings the safety and efficacy of intravenous treatments into question. In a report published in the September ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK), (“Takeda”) today announced that the United States Food and Drug ...
Phase II trial of high-dose interleukin-2 (IL-2) with priming and concomitant sargramostim (GM-CSF) in patients with advanced melanoma. Results: Ten patients have been treated with the OBL one-hour ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback